{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:37:00Z","timestamp":1770824220147,"version":"3.50.1"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,13]]},"DOI":"10.18632\/oncotarget.11054","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T15:28:21Z","timestamp":1470324501000},"page":"60074-60086","source":"Crossref","is-referenced-by-count":47,"title":["Upregulation of miR-181c inhibits chemoresistance by targeting <i>ST8SIA4<\/i> in chronic myelocytic leukemia"],"prefix":"10.18632","volume":"7","author":[{"given":"Lifen","family":"Zhao","sequence":"first","affiliation":[{"name":"College of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Health Sciences, University of Troms\u00f8, Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Dalian Medical University, Dalian, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Li","sequence":"additional","affiliation":[{"name":"College of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Miao","sequence":"additional","affiliation":[{"name":"College of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jia","sequence":"additional","affiliation":[{"name":"College of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"Stephenson","year":"1982","journal-title":"Nature"},{"key":"2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/cncr.26297","article-title":"Deregulated microRNAs in multiple myeloma","volume":"118","author":"Vartholomatos","year":"2012","journal-title":"Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"Tuschl","year":"2001","journal-title":"Science"},{"key":"4","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.1158\/0008-5472.CAN-08-1954","article-title":"MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer","volume":"68","author":"Liu","year":"2008","journal-title":"Cancer Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1479-5876-11-265","article-title":"MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1","volume":"11","author":"Chen","year":"2013","journal-title":"J Transl Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.leukres.2015.07.008","article-title":"Silencing of miR-21 sensitizes CML CD34+ stem\/progenitor cells to imatinib-induced apoptosis by blocking PI3K\/AKT pathway","volume":"39","author":"Jin","year":"2015","journal-title":"Leuk Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cas.12339","article-title":"Downregulation of miR-217 correlates with resistance of Ph(+) leukemia cells to ABL tyrosine kinase inhibitors","volume":"105","author":"Yokoyama","year":"2014","journal-title":"Cancer Sci"},{"key":"8","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1158\/0008-5472.CAN-13-1748","article-title":"Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S","volume":"74","author":"Qu","year":"2014","journal-title":"Cancer Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10719-015-9577-7","article-title":"Sialic acids: biomarkers in endocrinal cancers","volume":"32","author":"Ghosh","year":"2015","journal-title":"Glycoconj J"},{"key":"10","doi-asserted-by":"crossref","first-page":"e105403","DOI":"10.1371\/journal.pone.0105403","article-title":"Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy","volume":"9","author":"Horstkorte","year":"2014","journal-title":"PLoS One"},{"key":"11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11010-009-0147-9","article-title":"Human beta-galactoside alpha-2 3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity","volume":"331","author":"Safa","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"12","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1074\/jbc.M511826200","article-title":"The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer","volume":"281","author":"Taylor-Papadimitriou","year":"2006","journal-title":"J Biol Chem"},{"key":"13","first-page":"3986","article-title":"Akt\/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation","volume":"61","author":"Dennis","year":"2001","journal-title":"Cancer Res"},{"key":"14","first-page":"8203","article-title":"The phosphatidylinositide 3\u2032-kinase\/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412 an inhibitor of protein kinase C","volume":"61","author":"Pruschy","year":"2001","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1471-4159.2003.01538.x","article-title":"The role of phosphatidylinositol 3-kinase in neural cell adhesion molecule-mediated neuronal differentiation and survival","volume":"84","author":"Bock","year":"2003","journal-title":"J Neurochem"},{"key":"16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neuroscience.2010.02.067","article-title":"Divergent impact of the polysialyltransferases ST8SiaII and ST8SiaIV on polysialic acid expression in immature neurons and interneurons of the adult cerebral cortex","volume":"167","author":"Hildebrandt","year":"2010","journal-title":"Neuroscience"},{"key":"17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2184.2002.00228.x","article-title":"Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1 GM3 GD1A and GT1B","volume":"35","author":"Zhang","year":"2002","journal-title":"Cell Prolif"},{"key":"18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1471-4159.2004.02779.x","article-title":"An NCAM-derived FGF-receptor agonist the FGL-peptide induces neurite outgrowth and neuronal survival in primary rat neurons","volume":"91","author":"Bock","year":"2004","journal-title":"J Neurochem"},{"key":"19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/iub.1351","article-title":"alpha-2 8-Sialyltransferase Is Involved in the Development of Multidrug Resistance via PI3K\/Akt Pathway in Human Chronic Myeloid Leukemia","volume":"67","author":"Jia","year":"2015","journal-title":"IUBMB Life"},{"key":"20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/onc.2014.7","article-title":"Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia","volume":"34","author":"Jia","year":"2015","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/abbs\/gmr128","article-title":"miR-181a sensitizes a multidrug-resistant leukemia cell line K562\/A02 to daunorubicin by targeting BCL-2","volume":"44","author":"Xu","year":"2012","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00432-011-1137-3","article-title":"miR-181a sensitizes resistant leukaemia HL-60\/Ara-C cells to Ara-C by inducing apoptosis","volume":"138","author":"Wang","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/onc.2009.468","article-title":"TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3","volume":"29","author":"Ghoshal","year":"2010","journal-title":"Oncogene"},{"key":"24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/ijo.2014.2390","article-title":"miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1","volume":"45","author":"Ji","year":"2014","journal-title":"Int J Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"44466","DOI":"10.18632\/oncotarget.6298","article-title":"Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1755-8166-6-27","article-title":"Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia","volume":"6","author":"Knuutila","year":"2013","journal-title":"Mol Cytogenet"},{"key":"27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bcp.2012.01.007","article-title":"Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells","volume":"83","author":"Lee","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"28","doi-asserted-by":"crossref","first-page":"39654","DOI":"10.1074\/jbc.M111.276063","article-title":"ST6Gal-I regulates macrophage apoptosis via alpha2-6 sialylation of the TNFR1 death receptor","volume":"286","author":"Bellis","year":"2011","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"crossref","first-page":"22982","DOI":"10.1074\/jbc.M110.211375","article-title":"Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells","volume":"286","author":"Bellis","year":"2011","journal-title":"J Biol Chem"},{"key":"30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nsmb.3060","article-title":"Structure of human ST8SiaIII sialyltransferase provides insight into cell-surface polysialylation","volume":"22","author":"Strynadka","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Vaiana, Kurcon, Mahal. MicroRNA-424 Predicts a Role for beta-1 4 Branched Glycosylation in Cell Cycle Progression. 2016; 291:1529\u20131537.","DOI":"10.1074\/jbc.M115.672220"},{"key":"32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1423-0127-20-29","article-title":"Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a","volume":"20","author":"Martinez","year":"2013","journal-title":"J Biomed Sci"},{"key":"33","doi-asserted-by":"crossref","first-page":"11845","DOI":"10.1074\/jbc.M112.405993","article-title":"Reduction of the ST6 beta-galactosamide alpha-2,6-sialyltransferase 1 (ST6GAL1)-catalyzed sialylation of nectin-like molecule 2\/cell adhesion molecule 1 and enhancement of ErbB2\/ErbB3 signaling by microRNA-199a","volume":"288","author":"Takai","year":"2013","journal-title":"J Biol Chem"},{"key":"34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Gonzalez-Baron","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K pathway as drug target in human cancer","volume":"28","author":"Engelman","year":"2010","journal-title":"J Clin Oncol"},{"key":"36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.leukres.2008.06.010","article-title":"PI3K\/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines","volume":"33","author":"Hajos","year":"2009","journal-title":"Leuk Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"e80070","DOI":"10.1371\/journal.pone.0080070","article-title":"Differential effects of selective inhibitors targeting the PI3K\/AKT\/mTOR pathway in acute lymphoblastic leukemia","volume":"8","author":"Ottmann","year":"2013","journal-title":"PLoS One"},{"key":"38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/leu.2014.158","article-title":"Activation of the PI3K\/AKT pathway by microRNA-22 results in CLL B-cell proliferation","volume":"29","author":"Oppezzo","year":"2015","journal-title":"Leukemia"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8229","article-title":"miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"40","first-page":"197241","article-title":"MicroRNA181a Is Overexpressed in T-Cell Leukemia\/Lymphoma and Related to Chemoresistance","volume":"2015","author":"Zhao","year":"2015","journal-title":"Biomed Res Int"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T12:22:05Z","timestamp":1596716525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":40,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016,9,13]]}},"alternative-id":["11054","27527856"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11054","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}